|1.||Kalinin, Vladimir I: 1 article (05/2011)|
|2.||Adryjashchenko, Pelageya V: 1 article (05/2011)|
|3.||Avilov, Sergey A: 1 article (05/2011)|
|4.||Aminin, Dmitry L: 1 article (05/2011)|
|5.||Stonik, Valentin A: 1 article (05/2011)|
|6.||Zaporozhets, Tatiana S: 1 article (05/2011)|
|7.||Avilov, S A: 1 article (06/2010)|
|8.||Agafonova, I G: 1 article (06/2010)|
|9.||Kalinin, V I: 1 article (06/2010)|
|10.||Aminin, D L: 1 article (06/2010)|
06/01/2010 - "The highest effect occurs at a treatment once a day for 7 days before the tumor inoculation followed by Cumaside treatment once a day for 7 days. "
06/01/2010 - "Prophylactic treatment with Cumaside and subsequent therapeutic application of 5-fluorouracil suppressed the tumor growth by 43%."
05/01/2011 - "The animals administrated with Cumaside and irradiated were killed by pervisceral dislocation on days 4 and 9. Peripheral blood cell composition indexes, blood forming function and cell number in blood-forming organs and the number of pluripotent blood-forming stem cells were determined using standard procedures and the results compared with those of non-treated irradiated mice. "
06/01/2010 - "Nevertheless Cumaside has an antitumor activity against different forms of experimental mouse Ehrlich carcinoma in vivo both independently and in combination with cytostatics. "
06/01/2010 - "A new immunomodulatory lead Cumaside that is a complex of monosulfated triterpene glycosides from the sea cucumber Cucumaria japonica and cholesterol possesses significantly less cytotoxic activity against sea urchin embryos and Ehrlich carcinoma cells than the corresponding glycosides. "